Loading
GABA-A Antagonist·Toxicology & Antidotes
Reversal of conscious sedation (iatrogenic), pure benzodiazepine overdose in non-habituated patients
Max Dose
2 mg (STAT)
Half-life
40–80 mins
Seizure Risk
CRITICAL
Resedation
HIGH RISK
Overview
Competitive benzodiazepine receptor antagonist. Rapidly reverses benzodiazepine-induced sedation and respiratory depression.
Maximum Dose
Max 2 mg per acute reversal event.
Clinical Focus
Do NOT use in mixed overdoses or chronic benzo users. Stripping benzos off the receptor in a dependent patient will trigger uncontrollable, fatal status epilepticus.
Bottom Line
Flumazenil is the specific benzodiazepine antagonist for reversal of BZD sedation and overdose, but can precipitate seizures in chronic benzodiazepine users and has a shorter half-life than most BZDs.
Brand Names
Anexate
Parenteral
Ampoules (500 mcg/5 mL) for IV use only.
Prescribing & PBS
Hospital supply. Restricted.
Primary
Reversal of conscious sedation (iatrogenic), pure benzodiazepine overdose in non-habituated patients.
Clinical Place
Highly restricted in ED toxicology. Mostly used by anesthetists to wake patients up post-endoscopy.